Active Shortage

IRBESARTAN/HCTZ

SANIS HEALTH INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of IRBESARTAN/HCTZ in Canada?

Yes. IRBESARTAN/HCTZ 25MG 300MG has an active shortage reported to Health Canada (last updated June 6, 2024).

Why is IRBESARTAN/HCTZ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will IRBESARTAN/HCTZ be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength25MG 300MG

Last updated2024-06-06

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02372908

Strength

25MG 300MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE IRBESARTAN

Tier

Unrated

Last Updated

2024-06-06

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from SANIS HEALTH INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

200MG · DIN 02286254

400MG · DIN 02286262

100MG · DIN 02286246

400MG · DIN 02286564

70MG · DIN 02352966

10MG · DIN 02519844